Term
|
Definition
70 or Higher
Duration 3-5 mins |
|
|
Term
|
Definition
Dibucaine 40-60
Duration 1.5-2 times prolonged |
|
|
Term
|
Definition
Dibucaine Number < 30
Duration 4-8 hours longer |
|
|
Term
|
Definition
Serum K+ increases 0.5 mEq/L
Bradycardia resistant to atropine
Sore throat, myalgia
Myoglobinuria
Sustained Massester muscle contraction
Increased IOP, ICP, and gastric pressure |
|
|
Term
|
Definition
Allergy
MH
Infants
Male Children
Neuro cases
Open Globe Injuries
Denervation States
Hyperkalemia
Muscle Weakness
Pseudocholinesterase Deficiency |
|
|
Term
|
Definition
1- 1.5 mg/kg IV
3 mg/kg IM
Duration 3-5 mins
Onset 30-60 seconds |
|
|
Term
|
Definition
Succ doses > 2mg/kg
Tachyphylaxis, abrupt onset
Resembles non-depolarizers |
|
|
Term
|
Definition
|
|
Term
|
Definition
Volatile Agents
Aminoglycosides
LA
Anti-dysrhythmics
Diuretics
Magnesium and Lithium
Calcium Channel Blockers
Hypothermia
Respiratory Acidosis
Hyper/Hypo kalemia
Adrenocortical dysfunction |
|
|
Term
|
Definition
Hyperkalemia
Anticonvulsants
Burns
(enzyme induced) |
|
|
Term
Non-Depolarizer Contraindications |
|
Definition
Allergy
Inability to secure the airway
Inability to support ventilation
Myasthenia gravis- destruction of Ach receptors |
|
|
Term
|
Definition
Dense surgical block
Renal and Hepatic Metabolism |
|
|
Term
|
Definition
Weak surgical block
Hoffman elimination and Pseudocholinesterase |
|
|
Term
|
Definition
Aminosteroid- pancuronium, pipecuronium
Benzylisoquinoline- tubocurarine |
|
|
Term
Pancuronium Intubation Dose |
|
Definition
0.1 mg/kg
Peak 3-5 mins
Duration 60-90 mins |
|
|
Term
|
Definition
After succ 0.5 mg/kg
Maintenance: 0.01-0.02 mg/kg |
|
|
Term
|
Definition
Vagolytic- good for CV patients
Stay away from renally impaired
Good for long cases |
|
|
Term
|
Definition
Amintosteroid- vecuronium, rocuronium
Benzyliquinolines- atracurium, cisatracurium |
|
|
Term
|
Definition
0.1 mg/kg
Peak 1-2 mins
Duration 25-30 mins |
|
|
Term
|
Definition
After Succ- 0.05 mg/kg
Maintenance: 0.01-0.015 mg/kg
1 mcg/kg/min: drip |
|
|
Term
|
Definition
0.6-1.2 mg/kg
Peak 1-2 mins
Duration 25 mins |
|
|
Term
|
Definition
After succ 0.06-0.6 mg/kg
Maintenance- 0.1-0.15 mg/kg |
|
|
Term
|
Definition
0.5- 1 mg/kg
Peak 3-5 mins
Duration 20-25 mins |
|
|
Term
|
Definition
After succ: 0.2 mg/kg
Maintenance: 0.1 mg/kg |
|
|
Term
|
Definition
0.1-0.2 mg/kg
Peak 3-5 mins
Duration 20-25 min |
|
|
Term
|
Definition
After succ: 0.03 mg/kg
Maintenance: 0.01 mg/kg
0.4-4 mcg/kg/min: drip |
|
|
Term
|
Definition
0.25 mg/kg
Peak 2-3 mins
Duration 12-25 mins |
|
|
Term
|
Definition
After succ: 0.05- 0.1 mg/kg
Maintenance: 0.025 mg/kg |
|
|
Term
|
Definition
Intermediate Duration of Action
Benzylisoquinolinum furmate ester based compound
Testing phase
Histamine Release
Approx 71 min
Elimination: cysteine adduction and hydrolisis |
|
|
Term
|
Definition
Reversible > 25% twitch height
60-90 mins
Spontaneous recovery >0.9% TOF 130-220 mins |
|
|
Term
|
Definition
Edrophonium
Neostigmine
Pyridostigmine
Physostigmine and Echothiopate- medicine
Poisons- organophosphates and nerve gas |
|
|
Term
|
Definition
Reversibly binds to acetylchoinesterase
weaker bond that neostigmine |
|
|
Term
Neostigmine and Physostigmine MOA |
|
Definition
Reversibly binds to acetylcholinesterase
Contain carbamyl group that does hydrogen bond at esteratic site
Creates a more stable bond
1/2 time: 15-30 |
|
|
Term
|
Definition
50% Neo metabolized in the liver and metabolite 1/10th of activity
Young and elederly require less
Excretion altered in renal patients |
|
|
Term
|
Definition
Ulnar nerve--> adductor pectoralis
Facial nerve--> orbicularis oculi
Posterior tibial nerve--> flexor hallicus longus
Place distal electrode at the wrist
Sustain 5 sec tetany is extubation criteria |
|
|
Term
|
Definition
|
|
Term
|
Definition
90% Blocked
0.07 mg/kg
NG 5 mg/ G 1 mg |
|
|
Term
|
Definition
85% Blocked
0.05 mg/kg
N 3.5 mg/ G 0.7 mg |
|
|
Term
|
Definition
80% block
0.05 mg/kg
N 3.5 mg/G 0.7 mg |
|
|
Term
|
Definition
0-75% Blocked
0.03mg/kg
N 2 mg/ G 0.4 mg |
|
|
Term
|
Definition
0.5-1 mg/kg
Peak 0.8-2 mins
Duration: 66 mins
Give with atropine |
|
|
Term
|
Definition
0.03-0.07 mg/kg
Peak: 7-11 mins
Duration: 76 mins
Give with atropine or glycopyrulate |
|
|
Term
|
Definition
0.01-0.02 mg/kg
Onset 1 min
Duration: 30-60 mins
1/2 time 2.3 hours
0.1 mg minimum dose of atropine |
|
|
Term
|
Definition
1:5 ratio
Onset 2-3 mins
Duration 30-60 mins
1/2 time: 1.25 hours |
|
|
Term
Central Anticholinergic Syndrome |
|
Definition
Restlessness, hallucinations, somnolence, unconsciousness
Dry flush skin, tachycardia, photophobia, blurred vision, increase MV
Physostigmine 15-60 mcg/kg |
|
|
Term
Central Cholinergic Syndrome |
|
Definition
Confusion, ataxia, seizures, depressed ventilation, coma
SLUDGEM
Anticholinesterase overdose
Organophophate or nerve gas posioning
Atropine 35-70 mcg/kg |
|
|
Term
|
Definition
3.6 mg Sugammedex/ 1 mg Rocuronium
2/4 Twitches give 2 mg/kg > return to 4/4 in 2-4 mins |
|
|
Term
|
Definition
Mainly renal- stay away from renally impaired
Small hepatic
132 mins |
|
|
Term
|
Definition
Elimination dependent on renal and heptic function
50-110 mins |
|
|
Term
|
Definition
Elimination dependent on renal and hepatic function
87 mins |
|
|
Term
|
Definition
Elimination NOT dependent on renal and hepatic function
Hoffmann elimination
21 mins |
|
|
Term
|
Definition
Elimination NOT dependent on renal or hepatic function
Hoffman elimination |
|
|
Term
|
Definition
Possible dependent on renal and hepatic function
psuedocholinesterase 1-3 mins |
|
|